Ftse Mib
34.242,49
0,75%
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.596,93
0,42%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biodexa Pharmaceuticals PLC (BDRX) Biodexa Pharmaceuticals PLC (BDRX) Notizie

Biodexa Pharmaceuticals PLC

BDRX
1,0345
-0,0755 (-6,80%)
08 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202417:51GLOBEBiodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial..
26/4/202414:30GLOBEBiodexa Enters Into Exclusive License to eRapa™, a Phase 3..
19/4/202414:00GLOBEPreliminary Results for the Year Ended 31 December 2023
23/2/202414:30GLOBEBiodexa Announces Positive Top Line Phase I Clinical Trial..
13/2/202414:15APSBiotech Shares Bid Up Premarket Following 9.9% Institutional..
08/2/202414:30GLOBEBiodexa Reports 12 Month Survival in MAGIC-G1 Study of..
07/2/202414:30GLOBEBiodexa Announces Allowance of U.S. Patent Covering..
22/1/202414:30GLOBEBiodexa CEO Issues Shareholder Letter Highlighting Progress..
29/12/202310:05GLOBEBiodexa Appoints Ann Merchant to the Board of Directors
21/12/202322:00GLOBEBiodexa Announces Closing Of $6.0 Million Underwritten..
19/12/202314:42GLOBEBiodexa Announces Pricing of $5.2 Million Underwritten..
27/11/202315:00GLOBEBiodexa Enters Into Agreements to Acquire Exclusive..
03/10/202314:30GLOBEBiodexa Completes Recruitment of Cohort A in Study of MTX110..
29/9/202322:30GLOBEInterim results for the six months ended 30 June 2023
21/9/202314:30GLOBEBiodexa to Present Recruitment and Treatment Update in ..
28/7/202314:00GLOBEBiodexa Pharmaceuticals Launches New Corporate and Clinical..
24/7/202313:30GLOBEBiodexa Regain Compliance with NASDAQ Minimum Bid Price..
10/7/202314:00GLOBECompletion of Enrolment and Treatment in the Phase 1 Study..
06/7/202322:30GLOBEResults of Appeal of Delisting Determination
06/7/202314:15GLOBEPublication of Manuscript from the PNOC015 (a.k.a. MTD-201)..
22/6/202322:15GLOBEADR Ratio Change
20/6/202314:00GLOBEAppeal of Delisting Determination
15/6/202322:05GLOBEReceipt of NASDAQ Delisting Determination Plans to Appeal
14/6/202314:30GLOBEResults of Annual General Meeting and General Meeting
26/5/202322:05GLOBEBiodexa Pharmaceuticals PLC Announces Closing of $3.32..
24/5/202314:40GLOBEBiodexa Pharmaceuticals PLC Announces US$3.32 Million..
22/5/202322:15GLOBEPosting of Annual Report & Notice of AGM
18/5/202314:30GLOBEBiodexa Pharmaceuticals Enters into Non-binding Letter of..
Apertura: 1,08 Min: 0,988 Max: 1,09
Chiusura: 1,11

La tua Cronologia

NASDAQ
BDRX
Biodexa Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network